lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
2-amino-1-(4-bromophenyl)ethanone,hydrochloride | |
cas no.: | 5467-72-1 |
---|---|
synonyms: | |
formula: | c8h9brclno |
exact mass: | 248.95600 |
molecular weight: | 250.52000 |
psa: | 43.09000 |
logp: | 3.09280 |
properties
|
|
melting point: | 265oc |
---|---|
boiling point: | 322.8oc at 760 mmhg |
flash point: | 149oc |
refractive index: | 1.589 |
safety info
|
|
rtecs: | am5840000 |
---|---|
safety statements: | s26-s36 |
wgk germany: | 3 |
risk statements: | r36/37/38 |
hazard codes: | xi:irritant; |